Tenaya Therapeutics, Inc. (TNYA)

NASDAQ: TNYA · Real-Time Price · USD

0.7847

+0.0431 (5.81%)

At close: Aug 5, 2026, 4:00 PM EDT

0.7820

-0.0027 (-0.34%)

After-hours: Aug 5, 2026, 7:46 PM EDT

Tenaya Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1.34	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-
Gross Profit	1.34	-	-	-	-	-
Selling, General & Admin	22.4	24.72	29.21	33.16	31.08	18.41
Research & Development	61.61	68.61	86.74	98.04	94.54	54.39
Other Operating Expenses	23.19	-	-	-	-	-
Total Operating Expenses	107.2	93.33	115.95	131.19	125.62	72.81
Operating Income	-105.86	-93.33	-115.95	-131.19	-125.62	-72.81
Interest Income	2.72	2.68	4.74	7.06	1.95	0.11
Other Non-Operating Income (Expense)	0.03	0.05	0.08	0.05	0	-0.02
Total Non-Operating Income (Expense)	2.75	2.73	4.82	7.11	1.96	0.09
Pretax Income	-103.12	-90.6	-111.13	-124.08	-123.67	-72.72
Net Income	-103.12	-90.6	-111.13	-124.08	-123.67	-72.72
Net Income to Common	-103.12	-90.6	-111.13	-124.08	-123.67	-72.72
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	193	153	85	74	45	18
Shares Outstanding (Diluted)	193	153	85	74	45	18
Shares Change	73.68%	80.34%	14.96%	64.61%	152.75%	1724.33%
EPS (Basic)	-0.53	-0.59	-1.31	-1.68	-2.76	-4.10
EPS (Diluted)	-0.53	-0.59	-1.31	-1.68	-2.76	-4.10
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-52.59	-68.88	-91.53	-103.31	-125.05	-85.93
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-0.27	-0.45	-1.08	-1.40	-2.79	-4.85
Gross Margin	100.00%	-	-	-	-	-
Operating Margin	-7929.89%	-	-	-	-	-
Profit Margin	-7723.97%	-	-	-	-	-
FCF Margin	-3939.18%	-	-	-	-	-
EBITDA	-98.71	-84.9	-107.48	-122.51	-119.15	-69.85
EBITDA Margin	-7394.16%	-	-	-	-	-
EBIT	-105.86	-93.33	-115.95	-131.19	-125.62	-72.81
EBIT Margin	-7929.89%	-	-	-	-	-

SEC Filings: 10-K · 10-Q